| This week's sponsor is Premier Research. | |  | Rare Cancer Drug Research: What to Know Going In
Rare cancer drug research requires oncology and rare disease expertise and careful attention to trial design and regulatory demands. Get started with our white paper. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Tuesday, June 19, 2018 The data, taken from three patients, showed a 38% increase in a muscle protein that boys with DMD usually lack. |
|
|
| This week's sponsor is Catalent. | |  | |
Top Stories Wednesday, June 20, 2018 ITeos Therapeutics has raised $75 million (€64 million) to take two immuno-oncology assets into the clinic. The MPM Capital-led series B tees iTeos up to start dosing patients with an adenosine A2A antagonist later this year while expanding into new offices in Cambridge, Massachusetts. Wednesday, June 20, 2018 Eidos' $106 million IPO comes on the heels of a $64 million series B and will support phase 2 and phase 3 trials of its transthyretin amyloidosis drug. Monday, June 18, 2018 This informative eBook explores technology currently being used to improve clinical trial efficiency, while also offering a peek into the emerging technologies that will shape the future success of clinical trials. Wednesday, June 20, 2018 Novimmune has brought TG Therapeutics on board to help with the development of its CD47-CD19 bispecific antibody. TG will fund and run early-phase clinical trials of the treatment for hematologic B-cell malignancies, with Novimmune set to return to help out with the pivotal program. Wednesday, June 20, 2018 It’s turned out to be a challenging 2018 for Anika Therapeutics’ new CEO Joseph Darling—and a failed phase 3 trial for lead pipeline drug Cingal won’t make his job any easier. Tuesday, June 19, 2018 Organ-on-a-chip developer Emulate has gathered $36 million in series C financing and plans to expand its platform to include a wider range of disease models for drug efficacy testing. Wednesday, June 20, 2018 Atul Gawande, M.D., was officially named chief executive officer of the three-way partnership's newly formed company to address U.S. employee healthcare. Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Life Science Strategy Group Take this anonymous 10-minute survey to share your thoughts on leading eClinical technology solutions and earn up to $55 honoraria. Take the survey now! Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. | 
